coronavirus
induc
infect
cell
format
doubl
membran
vesicl
site
rna
replic
much
known
format
vesicl
although
recent
observ
indic
import
role
endoplasm
reticulum
format
mous
hepat
coronaviru
mhv
replic
complex
rc
show
mhv
replic
sensit
brefeldin
bfa
consist
express
dominantneg
mutant
known
mimic
action
drug
inhibit
mhv
infect
profoundli
immunofluoresc
analysi
quantit
electron
microscopi
demonstr
bfa
block
format
rc
per
se
rather
reduc
number
mhv
rna
replic
sensit
bfa
mdck
cell
known
express
bfaresist
guanin
nucleotid
exchang
factor
accordingli
individu
knockdown
golgiresid
target
bfa
transfect
small
interf
rna
sirna
show
critic
involv
mhv
rna
replic
cellular
effector
also
appear
involv
mhv
replic
sirna
target
small
gtpase
inhibit
mhv
infect
significantli
collect
result
demonstr
activ
requir
effici
mhv
rna
replic
reveal
earli
secretori
pathway
mhv
replic
complex
format
close
connect
citat
verheij
mh
raaben
mari
te
lintelo
eg
reggiori
f
et
al
mous
hepat
coronaviru
rna
replic
depend
activ
plo
pathog
virus
reli
cellular
host
factor
virtual
step
infect
cycl
howev
cellular
protein
requir
cellular
pathway
hijack
virus
hardli
elucid
positivestrand
rna
virus
assembl
infect
cell
replic
complex
rc
associ
intracellular
membran
induct
local
microenviron
like
advantag
viru
membran
associ
may
facilit
recruit
viral
cellular
compon
involv
rna
replic
altern
membran
associ
may
provid
shield
environ
prevent
activ
protect
antivir
host
cell
respons
like
mediat
interferon
coronavirus
belong
famili
envelop
positivestrand
rna
virus
order
nidoviral
upon
translat
viral
genom
rna
two
larg
polyprotein
approxim
amino
acid
synthes
autoproteolyt
cleavag
product
collect
form
rc
rc
associ
doubl
membran
vesicl
dmv
appear
cytoplasm
foci
analyz
fluoresc
light
microscopi
increas
number
cours
infect
plausibl
nonstructur
viral
protein
nsp
mediat
format
dmv
modifi
intracellular
membran
recruit
cellular
compon
need
recent
studi
suggest
endoplasm
reticulum
er
lipid
donor
compart
membranebound
coronaviru
rc
although
coloc
nsp
marker
endosom
golgi
autophagosom
also
describ
brefeldin
bfa
well
known
fungal
metabolit
induc
redistribut
golgi
protein
er
effect
result
block
transport
though
secretori
pathway
drug
inhibit
activ
adpribosyl
factor
arf
small
gtpase
target
larg
guanin
nucleotid
exchang
factor
gef
golgispecif
resist
factor
big
bfainhibit
gef
specif
bfa
lock
arf
gdp
bound
gef
therebi
block
gef
activ
earli
stage
reaction
prior
guanin
nucleotid
releas
larg
gef
function
er
golgi
transport
pathway
local
ci
transsid
golgi
complex
cellular
effector
gef
arf
divid
three
class
class
class
ii
arf
class
iii
class
arf
regul
assembl
coat
complex
onto
vesicl
bud
compart
along
secretori
pathway
activ
lipidmodifi
enzym
review
function
class
ii
arf
remain
larg
unclear
class
iii
thought
regul
endosom
membran
traffic
big
like
activ
distinct
subclass
arf
specif
locat
order
regul
differ
type
transport
rout
field
virolog
bfa
use
besid
studi
viral
protein
transport
viru
assembl
investig
format
rc
rna
replic
sever
positivestrand
rna
virus
exampl
polioviru
rna
replic
shown
sensit
bfa
presenc
drug
polioviru
replic
site
form
rna
replic
complet
block
remark
member
picornaviru
famili
appear
differ
sensit
bfa
wherea
echoviru
rna
replic
strongli
inhibit
bfa
rna
replic
encephalomyocard
viru
affect
parechoviru
exhibit
intermedi
sensit
rel
littl
known
host
pathway
involv
coronaviru
rna
replic
rc
format
recent
demonstr
import
role
er
gener
rc
mhv
local
organel
express
alon
recruit
replic
complex
infect
cell
furthermor
coronavir
replic
inhibit
er
export
machineri
block
use
kinas
inhibitor
express
domin
activ
mutant
cellular
protein
pathway
like
contribut
format
coronaviru
rc
well
studi
involv
bfasensit
pathway
mhv
replic
rc
format
result
demonstr
activ
requir
effici
mhv
rna
replic
moreov
togeth
recent
observ
relev
er
process
data
reveal
earli
secretori
pathway
mhv
replic
intim
connect
bfa
known
disturb
membran
traffic
cell
type
result
redistribut
golgi
protein
er
first
confirm
sensit
murin
cell
bfa
immunofluoresc
use
antibodi
direct
golgi
protein
marker
inde
treatment
cell
mgml
bfa
h
typic
golgi
stain
pattern
lost
concomit
reticular
redistribut
protein
marker
data
shown
next
test
whether
mhv
infect
sensit
bfa
therefor
cell
inocul
luciferaseexpress
recombin
mhveflm
presenc
absenc
mgml
bfa
h
inoculum
remov
cell
incub
either
presenc
absenc
bfa
h
pi
intracellular
luciferas
express
level
determin
rel
untreat
cell
luciferas
express
inhibit
bfa
present
h
pi
wherea
bfa
treatment
viru
inocul
minor
effect
report
gene
express
fig
although
latter
decreas
might
result
part
reduc
entri
neg
effect
bfa
mhv
replic
transcript
evid
profoundli
impair
mhv
report
gene
express
bfa
ad
post
inocul
h
pi
control
experi
effect
bfa
sindbi
viru
replic
cell
assay
use
sindbi
pseudoviru
particl
contain
luciferaseexpress
replicon
describ
previous
sindbi
viru
replic
affect
bfa
treatment
fig
result
indic
observ
effect
bfa
mhvdriven
luciferas
express
due
nonspecif
druginduc
toxic
although
demonstr
previou
studi
report
gene
express
mhv
reliabl
measur
coronaviru
replic
want
confirm
reduct
luciferas
express
result
correspond
decreas
viral
rna
synthesi
rather
inhibit
viral
protein
translat
end
similar
experi
shown
fig
perform
amount
intracellular
genom
viral
rna
determin
realtim
taqman
pcr
luciferas
express
level
amount
genom
rna
found
sever
reduc
bfa
ad
directli
viru
inocul
fig
wherea
less
profound
effect
observ
cell
treat
viru
inocul
similar
result
obtain
target
taqman
pcr
differ
region
viral
genom
data
shown
directli
check
effect
bfa
translat
viral
mrna
perform
addit
experi
cell
infect
high
multipl
recombin
viru
express
firefli
luciferas
subsequ
transfect
synthet
mrna
encod
renilla
luciferas
synthet
mrna
mimic
viral
mrna
contain
untransl
region
ident
found
viral
genom
cell
incub
presenc
absenc
bfa
h
pi
intracellular
renilla
firefli
luciferas
express
level
determin
result
show
bfa
treatment
inhibit
synthesi
renilla
luciferas
synthet
mrna
firefli
luciferas
express
driven
recombin
viru
sever
affect
fig
renilla
luciferas
express
also
affect
absenc
viral
infect
data
shown
togeth
result
indic
bfa
inhibit
mhv
rna
replic
translat
viral
mrna
affect
next
determin
post
inocul
period
mhv
replic
sensit
bfa
analyz
luciferas
express
level
reliabl
measur
rna
replic
thu
cell
infect
mhveflm
treat
bfa
overlap
h
period
end
incub
period
intracellular
luciferas
express
level
coronavirus
caus
agent
mani
respiratori
enter
infect
human
anim
virus
virtual
step
infect
cycl
depend
host
cellular
factor
first
crucial
step
entri
cell
coronavirus
assembl
replic
complex
rc
associ
characterist
newli
induc
membran
structur
cellular
pathway
hijack
plusstrand
rna
virus
creat
factori
elucid
studi
involv
secretori
pathway
mous
hepat
coronaviru
mhv
replic
use
drug
brefeldin
bfa
known
interfer
ergolgi
membran
traffic
inhibit
activ
adpribosyl
factor
arf
small
gtpase
observ
show
mhv
rna
replic
sensit
bfa
agreement
herewith
demonstr
use
variou
techniqu
bfasensit
guanidin
nucleotid
exchang
factor
downstream
effector
critic
import
coronaviru
replic
result
conclud
mhv
rna
replic
depend
activ
studi
provid
new
insight
close
connect
mhv
replic
earli
secretori
pathway
determin
compar
mocktreat
cell
result
show
replic
affect
throughout
cours
infect
fig
howev
effect
pronounc
earli
phase
infect
confirm
observ
bfa
inhibit
mhv
replic
also
prove
effect
drug
due
inhibit
gef
activ
next
analyz
extent
express
dominantneg
mutant
would
affect
mhv
infect
mutant
decreas
affin
gtp
follow
gdp
displac
remain
nucleotidefre
longer
period
wt
consequ
express
mirror
effect
bfa
addit
protein
includ
constitutiveact
mutant
persist
gtpbound
state
longer
wildtyp
arf
result
prolong
activ
express
latter
mutant
known
inhibit
transport
later
step
secretori
pathway
eg
vesicular
tubular
cluster
vtc
golgi
complex
golgi
stack
cell
transfect
plasmid
express
yfp
fusion
either
wild
type
transfect
cell
inocul
rfpexpress
recombin
mhvrfp
allow
flow
cytometr
analysi
mhv
replic
percentag
rfpposit
cell
yfpexpress
popul
determin
rel
wild
type
express
cell
fig
overexpress
wt
fusion
protein
significantli
affect
mhv
infect
compar
nontransfect
cell
data
shown
result
indic
overexpress
dominantneg
mutant
inhibit
mhv
infect
profoundli
therebi
confirm
result
obtain
bfa
contrast
express
constitutiveact
mutant
influenc
mhv
replic
bfa
known
affect
intracellular
vesicl
format
transport
mhv
replic
genom
associ
dmv
next
investig
effect
bfa
assembl
mhv
rc
first
check
whether
morpholog
integr
rc
affect
presenc
bfa
therefor
cell
infect
treat
bfa
minut
start
h
pi
subsequ
fix
process
immunofluoresc
use
antibodi
serv
protein
marker
mhv
replic
site
viral
structur
protein
known
resid
golgi
antibodi
reveal
typic
perinuclear
stain
pattern
treat
non
treat
infect
cell
fig
contrast
dispers
distribut
protein
observ
bfatreat
cell
reflect
collaps
golgi
wherea
nontreat
cell
protein
show
clear
golgilik
stain
fig
result
indic
form
replic
site
disrupt
bfa
subsequ
investig
whether
bfa
inhibit
rc
format
earli
infect
bfa
therefor
ad
cell
directli
inocul
stain
perform
h
pi
use
antibodi
although
perinuclear
stain
could
detect
bfatreat
cell
number
intens
contain
foci
clearli
reduc
compar
nontreat
cell
fig
next
investig
whether
puncta
repres
mhv
replic
site
therefor
studi
abil
foci
recruit
nucleocapsid
protein
n
protein
previous
shown
local
rc
three
parallel
cultur
cell
transfect
plasmid
code
mhv
ngfp
fusion
protein
h
post
transfect
two
infect
bfa
mgml
ad
one
latter
cultur
directli
inocul
h
pi
h
pi
cell
fix
subsequ
process
immunofluoresc
use
antibodi
fig
expect
ngfp
diffus
local
cytosol
noninfect
cell
indic
arrowhead
fig
contrast
cell
infect
mhv
fusion
protein
also
appear
foci
coloc
indic
arrow
fig
coloc
observ
mockand
bfatreat
cell
indic
foci
form
presenc
bfa
though
decreas
number
intens
correspond
replic
site
complet
agreement
luciferas
express
data
shown
result
demonstr
bfa
inhibit
complet
block
format
rc
studi
effect
bfa
dmv
ultrastructur
level
mhvinfect
cell
fix
h
pi
embed
epon
resin
order
analyz
electron
microscopi
dmv
indic
asterisk
fig
alway
seen
organ
cluster
often
locat
perinuclear
area
morpholog
dimens
vesicl
similar
previous
describ
dmv
harbor
rc
importantli
vesicl
observ
mockinfect
cell
data
shown
fig
show
close
view
dmv
transluc
interior
surround
doubl
membran
presenc
inner
weblik
structur
like
artifici
treatment
cell
bfa
h
led
expect
disappear
appar
golgi
complex
concomit
expans
er
volum
shown
cell
vesicl
morpholog
almost
ident
present
non
bfatreat
cell
observ
fig
howev
number
dmv
significantli
decreas
bfatreat
cell
compar
nontreat
cell
vs
averag
per
section
fig
reduct
number
dmv
like
underestim
em
section
includ
analys
least
one
replic
vesicl
could
detect
strikingli
doubl
membran
replic
vesicl
visual
pronounc
bfatreat
cell
untreat
cell
fig
might
relat
swell
er
observ
bfa
addit
dmv
slightli
bigger
bfatreat
cell
nm
compar
nm
nontreat
cell
fig
although
signific
latter
observ
clear
present
overal
ultrastructur
analysi
mhvinfect
cell
confirm
treatment
cell
bfa
decreas
number
replic
vesicl
consist
reduc
viral
rna
replic
presenc
bfa
address
arf
gef
contribut
mhv
replic
next
focus
bfasensit
gef
local
secretori
pathway
ie
first
studi
whether
coronaviru
replic
affect
bfa
mdck
cell
cell
bfaresist
golgiapparatu
due
point
mutat
f
van
kuppeveld
unpublish
result
howev
transgolgi
network
tgn
endocyt
organel
mdck
cell
still
sensit
bfa
mdck
cell
stabli
express
receptor
mdck
mhvr
inocul
mhveflm
bfa
ad
either
h
pi
h
pi
inocul
result
show
mhv
replic
affect
bfa
treatment
cell
either
time
period
fig
point
toward
possibl
involv
bfasensit
protein
mhv
replic
confirm
rather
requir
mhv
replic
one
gef
specif
singularli
deplet
rna
interfer
assay
mhv
replic
target
gene
three
sirna
oligo
transfect
cell
h
post
transfect
cell
infect
luciferaseexpress
six
h
later
number
viabl
cell
luciferas
express
level
determin
fig
describ
materi
method
fig
result
present
rel
luciferas
express
rii
level
ie
luciferas
activ
express
rel
mocktreat
cell
correct
number
viabl
cell
transfect
control
sirna
target
housekeep
protein
glyceraldehyd
dehydrogenas
gapdh
chang
rii
wherea
sirna
target
firefli
luciferas
reduc
rii
demonstr
effici
sirna
transfect
importantli
downregul
result
drastic
inhibit
rii
wherea
sirna
target
signific
effect
fig
almost
ident
result
obtain
three
sirna
oligo
gene
singli
transfect
data
shown
parallel
experi
demonstr
downregul
major
target
similar
phenotyp
effect
mhv
replic
seen
fig
prove
specif
result
perform
seri
control
first
specif
knockdown
respect
mrna
sirna
transfect
confirm
quantit
rtpcr
analysi
h
transfect
sirna
correspond
mrna
level
found
reduc
respect
mrna
level
affect
transfect
noncorrespond
sirna
demonstr
specif
mrna
deplet
data
shown
second
function
knockdown
protein
level
demonstr
cotransfect
plasmid
encod
togeth
either
sirna
respect
approach
chosen
unavail
specif
antiantibodi
twentyfour
h
transfect
cell
fix
yfpposit
cell
count
fig
demonstr
express
prohibit
presenc
specif
sirna
next
analyz
whether
inhibit
mhv
replic
deplet
coincid
collaps
golgi
complex
observ
bfa
treatment
cell
transfect
sirna
target
subsequ
process
immunofluoresc
h
post
transfect
use
antibodi
sirnatransfect
cell
stain
indistinguish
mocktreat
cell
fig
indic
loss
lead
collaps
golgi
er
complet
accord
result
volpicellidaley
et
al
demonstr
deplet
alon
suffici
mimic
bfa
effect
golgi
complex
rather
requir
simultan
deplet
establish
deplet
affect
mhv
replic
profoundli
studi
whether
format
mhv
rc
similarli
affect
end
perform
similar
knock
experi
transfect
sirna
target
either
subsequ
infect
cell
recombin
mhv
express
addit
copi
fuse
gfp
fusion
protein
coloc
provid
addit
marker
rc
data
shown
six
hour
infect
cell
fix
process
immunofluoresc
antibodi
mock
transfect
cell
mani
gfp
posit
foci
observ
larg
coloc
fig
agreement
rel
luciferas
express
valu
shown
fig
cell
number
intens
posit
foci
reduc
similar
observ
bfatreat
cell
fig
appar
number
mhv
rc
reduc
cell
strikingli
howev
appear
express
much
affect
deplet
either
hardli
gfp
fluoresc
could
detect
express
directli
viral
genom
fusion
protein
express
subgenom
mrna
henc
replic
transcript
requir
express
result
therefor
indic
fewer
rc
form
absenc
either
rc
also
impair
rna
synthesi
conclus
result
demonstr
deplet
reduc
mhv
replic
well
number
rc
furthermor
result
indic
rc
form
absenc
either
less
activ
addit
inhibit
mhv
replic
caus
collaps
golgi
apparatu
per
se
cell
viru
replic
sever
affect
wherea
overal
morpholog
golgi
complex
unalt
next
address
question
whether
recruit
replic
site
end
cell
express
wild
type
fuse
yfp
infect
either
fix
earli
h
late
h
time
point
pi
identifi
replic
site
immunostain
cell
antibodi
figur
show
predominantli
local
golgi
apparatu
indic
arrowhead
left
panel
fig
h
pi
h
pi
h
pi
minor
cell
coloc
observ
indic
arrow
fig
coloc
could
observ
infect
cell
h
pi
similar
result
obtain
data
shown
mani
downstream
effector
describ
list
still
grow
one
best
known
function
involv
regul
copimedi
vesicular
transport
bfasensit
polioviru
copi
found
local
replic
vesicl
studi
whether
similar
recruit
copi
replic
vesicl
occur
mhv
replic
determin
local
mhvinfect
cell
thu
cell
infect
recombin
viru
allow
us
directli
visual
replic
vesicl
without
perform
immunostain
antibodi
desir
antibodi
accop
two
subunit
copi
coat
antibodi
rais
rabbit
h
pi
cell
fix
process
immunofluoresc
analysi
use
accop
antibodi
result
show
addit
diffus
stain
throughout
cell
copi
primarili
local
golgilik
pattern
fig
copi
coloc
posit
site
indic
copi
recruit
replic
site
mhv
anoth
well
known
effector
phospholipas
pld
lipidmetabol
enzym
involv
membran
dynam
vesicular
transport
analyz
whether
rc
recruit
pld
cell
transfect
construct
express
fuse
gfp
subsequ
infect
cell
fix
h
pi
identifi
replic
site
immunostain
cell
antibodi
coloc
rc
could
observ
fig
furthermor
specif
inhibit
pld
affect
mhv
luciferas
express
compar
control
fig
studi
requir
examin
role
effector
final
studi
whether
normal
vesicular
traffick
affect
mhvinfect
cell
investig
made
use
gaussia
report
gene
protein
product
secret
upon
express
cell
transfect
plasmid
encod
gene
control
cmv
promot
subsequ
infect
either
mockinfect
treat
bfa
h
pi
intracellular
extracellular
level
gaussia
luciferas
measur
thu
ratio
luciferas
activ
cell
lysat
cultur
supernat
determin
condit
mockinfect
cell
almost
total
amount
gaussia
luciferas
found
cultur
supernat
mhvinfect
cell
amount
secret
gaussia
luciferas
decreas
fig
bfa
treatment
inhibit
expect
gaussia
protein
secret
almost
complet
conclud
although
mhv
rna
replic
depend
activ
mhv
infect
drastic
impair
secretori
pathway
result
unexpect
coronavirus
requir
function
secretori
pathway
releas
progeni
virion
rna
virus
use
manipul
cellular
membran
assembl
replic
transcript
structur
other
shown
coronavirus
exploit
earli
secretori
pathway
way
understood
report
demonstr
use
sever
differ
approach
mhv
requir
function
pathway
effici
rna
replic
first
show
mhv
sindbi
viru
replic
sensit
bfa
murin
cell
second
observ
mhv
replic
sensit
bfa
mdck
cell
contain
bfaresist
third
show
specif
sirnabas
knockdown
bfasensit
gef
strongli
affect
mhv
infect
fourth
also
downstream
effector
appear
requir
effici
mhv
replic
shown
inhibit
mhvdriven
report
gene
express
sirnamedi
regul
well
express
inact
mutant
inhibit
coronaviru
rna
replic
presenc
bfa
either
caus
direct
inhibit
rc
format
result
reduc
rna
replic
inhibit
rna
replic
via
anoth
mechan
result
reduc
de
novo
format
rc
though
difficult
distinguish
two
scenario
result
indic
latter
option
plausibl
although
bfa
reduc
number
rc
format
complet
block
demonstr
immunofluoresc
stain
rc
use
antibodi
quantit
electron
microscopi
appar
bfa
prevent
format
rc
translat
incom
genom
rna
addit
mhv
replic
inhibit
bfa
throughout
infect
earli
infect
inhibit
profound
later
time
point
mani
transcript
activ
rc
alreadi
form
furthermor
inhibit
report
gene
express
presenc
bfa
deplet
either
complet
agreement
reduc
number
rc
result
also
indic
rc
form
absenc
less
activ
therefor
hypothes
bfa
inhibit
mhv
rna
replic
affect
rc
matur
function
rather
rc
format
per
se
fig
replic
sever
virus
shown
sensit
bfa
virus
includ
polioviru
grapevin
fanleaf
nepoviru
mhv
studi
appear
use
erderiv
membran
format
rc
respect
strikingli
picornavirus
belong
differ
genera
found
differ
sensit
bfa
suggest
correspond
differ
assembl
rc
replic
equin
arteriviru
distant
rel
coronavirus
observ
sensit
bfa
nidovirus
studi
date
unlik
polioviru
hardli
recruit
coronaviru
rc
therefor
hypothes
downstream
effector
involv
mhv
replic
date
downstream
effector
identifi
one
might
thu
somehow
implic
function
mhv
rc
well
known
effector
copi
picornavirus
bfa
sensit
suggest
correl
recruit
copi
site
howev
coloc
copi
mhv
rc
could
observ
agreement
almost
complet
absenc
site
addit
coronaviru
rc
coloc
coronaviru
replic
affect
inhibit
phospholipas
lipidmetabol
enzym
involv
membran
dynam
vesicular
transport
might
pathway
simpli
function
deliv
lipid
rc
agreement
herewith
cerulenin
inhibitor
phospholipid
biosynthesi
sever
inhibit
mhv
replic
cam
de
haan
unpublish
result
nonetheless
observ
inhibit
mhv
infect
bfa
treatment
probabl
indirect
consequ
collaps
golgi
complex
unlik
bfa
treatment
deplet
affect
morpholog
golgi
complex
fig
consist
herewith
anoth
recent
studi
show
deplet
affect
golgi
morpholog
protein
transport
sever
studi
indic
coronaviru
replic
er
close
connect
electron
microscop
analys
infect
cell
show
partial
coloc
coronaviru
replicas
protein
solubl
er
resid
protein
disulfid
isomeris
dmv
often
found
close
proxim
er
occasion
continu
associ
furthermor
express
absenc
coronaviru
infect
protein
insert
er
becam
modifi
addit
nlink
sugar
wherea
express
tag
mhv
mhvinfect
cell
result
recruit
protein
replic
complex
addit
coronaviru
replic
inhibit
er
export
machineri
block
use
kinas
inhibitor
express
dominantact
mutant
small
gtpase
show
use
sever
approach
mhv
rna
replic
also
depend
activ
appar
intim
associ
exist
earli
secretori
pathway
mhv
replic
interestingli
wherea
block
rc
format
complet
case
activ
impair
bfa
rather
appear
rc
form
absenc
less
activ
suggest
role
protein
rc
matur
function
fig
clearli
investig
need
unravel
precis
mechan
secretori
pathway
contribut
biogenesi
function
coronaviru
rc
rna
replic
cell
gener
transfect
hela
cell
obtain
mpicbg
highthroughput
technolog
develop
studio
express
plasmid
pmhvr
describ
murin
madindarbi
canin
mdck
mhvr
cell
stabli
express
mhv
receptor
maintain
monolay
cultur
dulbecco
modifi
eagl
medium
dmem
cambrex
contain
fetal
calf
serum
fc
iu
penicillinml
mg
streptomycinml
life
technolog
mgml
life
technolog
paisley
uk
split
cell
ie
cell
stabli
express
sindbi
viru
structur
protein
maintain
glasgow
mem
invitrogen
contain
fc
iu
penicillinml
mg
streptomycinml
mgml
mgml
hygromycin
b
boehring
gmbh
use
gener
sindbi
pseudoviru
particl
contain
replicon
express
firefli
luciferas
end
firefli
luciferas
gene
clone
vector
invitrogen
use
convent
clone
procedur
result
vector
subsequ
process
accord
polo
et
al
produc
pseudoviru
particl
cell
use
propag
wild
type
recombin
mhv
base
strain
recombin
virus
express
firefli
luciferas
gene
mhveflm
red
fluoresc
protein
rfp
gene
describ
recombin
viru
express
fluoresc
protein
gfp
fusion
protein
gener
similar
way
describ
previous
briefli
fusion
construct
clone
behind
addit
transcript
regul
sequenc
deriv
rna
transcript
vector
target
recombin
obtain
recombin
perform
describ
antibodi
direct
mhv
kindli
provid
denison
vanderbilt
univers
medic
center
nashvil
usa
amino
terminu
mhv
protein
kindli
provid
j
fleme
univers
wisconsin
madison
usa
accopi
antiaccopi
kindli
provid
f
wieland
univers
heidelberg
germani
golgi
marker
latter
two
bd
transduct
laboratori
figur
model
mhv
rc
link
earli
secretori
pathway
two
major
step
anterograd
protein
secret
rout
review
link
mhv
rc
format
andor
rna
replic
first
transport
protein
er
requir
er
exit
site
format
control
block
earli
step
use
drug
express
domin
mutant
block
mhv
replic
profoundli
next
er
exit
site
develop
form
de
novo
vesiculartubular
cluster
vtc
also
call
ergic
requir
step
block
bfa
express
dominantneg
mutant
downregul
use
sirna
also
involv
mhv
rc
format
manuscript
howev
fulli
function
secretori
pathway
essenti
dominantact
mutant
block
transport
vtc
cisgolgi
impair
mhv
replic
san
jose
usa
use
conjug
secondari
antibodi
purchas
jackson
immunoresearch
laboratori
plasmid
contain
differ
gene
frame
either
gfp
yellow
fluoresc
protein
yfp
tag
obtain
g
romero
c
jackson
respect
encod
wild
type
protein
fuse
yfp
encod
dominantneg
dominantact
mutant
fuse
yfp
gfp
respect
pnegfp
plasmid
encod
mhv
nucleocapsid
n
protein
extend
cterminu
gfp
construct
clone
pcr
fragment
specifi
n
gene
without
stop
codon
clontech
use
convent
clone
procedur
plasmid
encod
gaussia
report
gene
behind
cmv
promot
gener
replac
egfp
gene
clontech
gaussia
luciferas
gene
pglucbas
new
england
biolab
use
convent
clone
method
viral
express
plasmid
gener
clone
synthet
dna
segment
genscript
correspond
extrem
nt
extrem
nt
genom
separ
nhei
restrict
site
flank
promot
poli
sequenc
upstream
downstream
respect
subsequ
code
region
renilla
luciferas
obtain
prlnull
promega
clone
nheidigest
vector
subconflu
monolay
cell
grown
coverslip
tissu
cultur
dish
overlaid
transfect
medium
consist
ml
optimem
invitrogen
contain
ml
lipofectamin
invitrogen
mg
dna
hour
medium
replac
dmem
contain
fc
h
transfect
cell
process
indic
plasmid
linear
use
paci
restrict
site
directli
downstream
poli
sequenc
subsequ
rna
transcript
produc
use
messagemachin
kit
ambion
accord
manufactur
instruct
transcript
pmol
rna
transfect
mockor
cell
h
pi
use
lipofectamin
invitrogen
next
cell
treat
without
mgml
bfa
h
h
pi
cell
lyse
intracellular
renilla
firefli
luciferas
activ
measur
dualluciferas
assay
kit
promega
accord
manufactur
protocol
cell
fix
use
paraformaldehyd
solut
phosphat
buffer
salin
pb
subsequ
permeabil
pb
next
cell
incub
h
first
antibodi
dilut
pb
contain
normal
goat
serum
sever
wash
step
cell
incub
appropri
dilut
secondari
antibodi
buffer
h
three
subsequ
wash
step
coverslip
mount
fluosav
calbiochem
immunofluoresc
stain
analyz
use
confoc
laserscan
microscop
leica
gfpyfp
fitc
excit
nm
nm
viru
replic
quantifi
determin
either
virusdriven
luciferas
express
level
amount
genom
rna
end
mdck
mhvr
cell
inocul
multipl
infect
moi
mhveflm
sindbi
pseudoviru
particl
presenc
absenc
mg
ml
bfa
dmem
h
cultur
medium
replac
dmem
contain
fc
antibiot
presenc
absenc
mgml
bfa
indic
time
point
luciferas
express
cell
determin
use
firefli
luciferas
assay
system
promega
accord
manufactur
instruct
use
singletub
luminomet
turner
design
altern
rna
isol
cell
use
qiagen
rneasi
kit
qiagen
accord
manufactur
protocol
taqman
singletub
revers
transcriptionpcr
rtpcr
assay
pe
biosystem
foster
citi
california
usa
perform
essenti
describ
de
haan
et
al
reaction
perform
triplic
accord
manufactur
instruct
use
taqman
rtpcr
kit
pe
biosystem
abi
prism
sequenc
detector
small
interf
si
rnamedi
knockdown
experi
sirna
duplex
target
differ
site
within
code
sequenc
design
obtain
ambion
inc
three
sirna
per
gene
nucleotid
sequenc
avail
request
sirna
target
gapdh
luciferas
ambion
taken
along
control
experi
one
day
seed
cell
transfect
final
concentr
nm
sirna
use
oligofectamin
invitrogen
seventytwo
h
transfect
cell
inocul
moi
approxim
mocktreat
cell
becam
infect
h
post
infect
pi
cell
number
viabil
measur
assay
accord
manufactur
protocol
roch
diagnost
gmbh
subsequ
medium
replac
dmem
lack
phenol
red
cambrex
steadylit
ht
firefli
luciferas
substrat
perkin
elmer
ad
luciferas
express
determin
use
luminesc
plate
reader
berthold
centro
lb
sirna
experi
perform
triplic
well
luciferas
valu
correct
cell
number
viabil
determin
assay
rel
mocktreat
cell
valid
function
knockdown
target
gene
mrna
level
gene
determin
sirna
transfect
use
taqman
gene
express
assay
appli
biosystem
ca
usa
accord
manufactur
protocol
determin
whether
sirna
target
gene
effect
deplet
cell
correspond
protein
sirna
transfect
experi
perform
ng
plasmid
encod
either
ad
transfect
mixtur
contain
correspond
sirna
twentyfour
h
transfect
cell
fix
repres
imag
taken
autom
cellworxtm
microscop
appli
precis
object
cell
transfect
inocul
mhvrfp
moi
h
post
transfect
two
h
pi
mm
peptid
ad
inhibit
syncytia
format
h
pi
cell
collect
fix
use
paraformaldehyd
solut
two
wash
pb
sampl
analyz
employ
facscalibur
tm
flow
cytomet
becton
dickinson
gate
yfpgfpposit
cell
forward
side
scatter
limit
cell
popul
similar
express
level
select
yfpgfpposit
popul
fraction
cell
express
rfp
determin
cell
infect
treat
h
pi
without
mgml
bfa
resuspend
glutaraldehyd
cacodyl
buffer
ph
least
h
room
temperatur
rt
buffer
replac
fresh
one
fixat
continu
overnight
cell
centrifug
wash
time
cacodyl
buffer
postfix
oso
ferrocyanid
min
next
cell
pellet
wash
time
distil
water
left
sit
last
wash
min
centrifug
resuspend
warm
low
melt
point
agar
roch
basel
switzerland
immedi
spun
solidif
agar
ice
tip
contain
cell
cut
small
mm
block
block
dehydr
immerg
increas
amount
ethanol
time
incub
rotatori
wheel
least
min
rt
step
amalgam
follow
other
oxid
merck
haarlem
netherland
epon
resin
min
oxid
epon
resin
min
oxideepon
min
epon
resin
overnight
epon
solut
prepar
mix
g
glycid
ether
g
acid
anhydrid
g
methylnad
anhydrid
ml
benzyldimethylamin
serva
heidelberg
germani
epon
resin
replac
follow
day
freshli
made
resin
incub
continu
h
rt
centrifug
rpm
min
epon
resin
polymer
heat
sampl
day
nm
section
cut
use
ultracut
e
ultramicrotom
leica
microsystem
transfer
formvar
carbonco
copper
grid
section
stain
first
uranyl
acet
min
rt
leadcitr
solut
mm
lead
nitrat
mm
sodium
citrat
ph
min
view
analysi
em
section
perform
use
electron
microscop
dmv
defin
base
two
follow
morpholog
criteria
typic
doubl
membran
presenc
previous
describ
weblik
structur
proxim
size
number
dmv
control
bfatreat
cell
determin
analyz
randomli
select
cell
profil
result
statist
analyz
student
ttest
